Camtek plans Rule 144 sale of 415 shares

Camtek Ltd filed a notice of proposed sale of 415 ordinary shares under Rule 144.

Rhea-AI Filing Summary

Camtek Ltd filed a notice of proposed sale of 415 ordinary shares under Rule 144. The shares were originally issued upon vesting of RSUs on 04/01/2025 for no cash consideration. Oppenheimer & Co. Inc. is listed as the broker, with an aggregate market value of $68,230.15 for the planned sale and 45,828,133 ordinary shares outstanding. The approximate sale date is 08/12/2026 on Nasdaq.

Key Figures

Shares to be sold: 415 shares Aggregate market value: $68,230.15 Shares outstanding: 45,828,133 shares +2 more

5 metrics

Shares to be sold 415 shares Ordinary shares covered by Rule 144 notice

Aggregate market value $68,230.15 Value of 415 ordinary shares to be sold

Shares outstanding 45,828,133 shares Ordinary shares outstanding for Camtek Ltd

Approximate sale date 08/12/2026 Planned sale date for the 415 shares on Nasdaq

RSU vesting date 04/01/2025 Date shares were issued upon vesting of RSUs

Key Terms

Rule 144, ordinary shares, RSUs, aggregate market value

4 terms

Rule 144 regulatory

"notice of proposed sale of 415 ordinary shares under Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

ordinary shares financial

"Ordinary Shares | Oppenheimer & Co. Inc. 85 Broad St."

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

RSUs financial

"Shares issued upon vesting of RSUs | CAMTEK LTD"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

aggregate market value financial

"415 | 68230.15 | 45828133 | 08/12/2026 | Nasdaq"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Camtek (CAMT) disclose in this Rule 144 notice?

Camtek discloses a proposed sale of 415 ordinary shares under Rule 144. The filing lists the broker, aggregate market value, shares outstanding, and an approximate sale date on Nasdaq.

How many Camtek (CAMT) shares are planned to be sold and at what value?

The notice covers a planned sale of 415 ordinary shares of Camtek Ltd with an aggregate market value of $68,230.15, as indicated in the filing’s securities information table.

When were the Camtek (CAMT) shares in this Rule 144 filing acquired?

The 415 shares were issued upon vesting of RSUs on 04/01/2025. The filing notes that no cash consideration was paid, as the shares resulted from the vesting of restricted stock units.

When is the planned sale date for the Camtek (CAMT) shares under Rule 144?

The approximate sale date for the 415 ordinary shares is 08/12/2026. The filing also indicates that the shares are to be sold on Nasdaq through Oppenheimer & Co. Inc.

How many Camtek (CAMT) shares are outstanding according to this filing?

The filing reports that 45,828,133 ordinary shares of Camtek Ltd are outstanding. This figure provides context for the size of the proposed 415-share Rule 144 sale relative to total shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/13/2026 - 07:31 AM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001973444
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CAMTEK LTD
SEC File Number	000-30664
Address of Issuer	INDUSTRIAL ZONE PO BOX 544 MIGDAL HAEMEK ISRAEL 23150
Phone	972-4-604-8100
Name of Person for Whose Account the Securities are To Be Sold	Geva-Dvash Orit
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	415	68230.15	45828133	08/12/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	04/01/2025	Shares issued upon vesting of RSUs	CAMTEK LTD			415	04/01/2025	No consideration, shares issued upon vesting of RSUs

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/12/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Orit Geva Dvash By: /s/ Yohanan Azriel Title: Authorized Signatory, Oppenheimer Israel (pursuant to delegation)
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)